Quinolone-isoniazid hybrids: synthesis and preliminary cytotoxicity and anti-tuberculosis evaluation.

Clicks: 358
ID: 104492
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #8 of 44 articles by views in medchemcomm

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Herein, we propose novel quinolones incorporating an INH moiety as potential drug templates against TB. The quinolone-based compounds bearing an INH moiety attached a hydrazide-hydrazone bond were synthesised and evaluated against H37Rv (MTB). The compounds were also evaluated for cytotoxicity against HeLa cell lines. These compounds showed significant activity (MIC) against MTB in the range of 0.2-8 μM without any cytotoxic effects. Compounds (MIC; 0.9 μM), (MIC; 0.2 μM), (MIC; 0.8 μM) and compound (MIC; 0.8 μM), the most active compounds in this series, demonstrate activities on par with INH and superior to those reported for the fluoroquinolones. The SAR analysis suggests that the nature of substituents at positions -1 and -3 of the quinolone nucleus influences anti-MTB activity. Aqueous solubility evaluation and metabolic stability of compound highlights favourable drug-like properties for this compound class.
Reference Key
beteck2019quinoloneisoniazidmedchemcomm Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Beteck, Richard M;Seldon, Ronnett;Jordaan, Audrey;Warner, Digby F;Hoppe, Heinrich C;Laming, Dustin;Legoabe, Lesetja J;Khanye, Setshaba D;
Journal medchemcomm
Year 2019
DOI
10.1039/c8md00480c
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.